Skip to main content
Top
Published in: Supportive Care in Cancer 8/2006

01-08-2006 | Review Article

The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline

Authors: Amanda Bolderston, Nancy S. Lloyd, Rebecca K. S. Wong, Lori Holden, Linda Robb-Blenderman, and the Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-based Care

Published in: Supportive Care in Cancer | Issue 8/2006

Login to get access

Abstract

Goals of work

To develop a practice guideline report on the questions: What are the optimal methods to prevent acute skin reactions (occurring within the first 6 months of irradiation) related to radiation therapy? What are the optimal methods to manage acute skin reactions related to radiation therapy?

Materials and methods

Cancer Care Ontario’s Supportive Care Guidelines Group (SCGG) conducted a systematic review of literature on this topic. Evidence-based recommendations were formulated to guide clinical decision making, and a formal external review process was conducted to validate the relevance of these opinions for Ontario practitioners.

Main results

Twenty-eight trials meeting the inclusion criteria were identified. Of the twenty-three trials that evaluated preventative methods, washing was the only practice which significantly prevented skin reaction. Some evidence suggested topical steroid creams and calendula ointment might be effective. None of the five trials evaluating skin reaction management detected a positive effect using steroid cream, sucralfate cream, or dressings.

Conclusions

Skin washing, including gentle washing with water alone with or without mild soap, should be permitted in patients receiving radiation therapy to prevent acute skin reaction. There is insufficient evidence to support or refute specific topical or oral agents for the prevention or management of acute skin reaction. In the expert opinion from the SCGG, the use of a plain, non-scented, lanolin-free hydrophilic cream may be helpful in preventing radiation skin reactions. In addition, a low dose (i.e., 1%) corticosteroid cream may be beneficial in the reduction of itching and irritation.
Footnotes
1
“Gentle washing” involves using lukewarm water and taking care not to rub the skin. Showers should also be lukewarm and should have low pressures.
 
2
“Mild soap” is defined as a pH-balanced, non-scented product that does not contain lanolin. There is no evidence to suggest that one type of mild soap is preferable to another. However, in one study that rated the irritant quality of 18 soaps, “Dove” was the only soap classified as mild and may, therefore, be considered [17].
 
Literature
1.
go back to reference Balzarini A, Felisi E, Martini A et al (2000) Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: a randomized, double-blind clinical trial. Br Homeopath J 89:8–12PubMedCrossRef Balzarini A, Felisi E, Martini A et al (2000) Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: a randomized, double-blind clinical trial. Br Homeopath J 89:8–12PubMedCrossRef
2.
go back to reference Barkham AM (1993) Radiotherapy skin reactions and treatments. Prof Nurse 8:732–736PubMed Barkham AM (1993) Radiotherapy skin reactions and treatments. Prof Nurse 8:732–736PubMed
3.
go back to reference Bolderston A (2002) Skin care recommendations during radiotherapy: a survey of Canadian practice. Can J Med Radiat Technol 34:3–11CrossRef Bolderston A (2002) Skin care recommendations during radiotherapy: a survey of Canadian practice. Can J Med Radiat Technol 34:3–11CrossRef
4.
go back to reference Bostrom A, Lindman H, Swartling C et al (2001) Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiother Oncol 59:257–265PubMedCrossRef Bostrom A, Lindman H, Swartling C et al (2001) Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study. Radiother Oncol 59:257–265PubMedCrossRef
6.
go back to reference Browman GP, Levine MN, Mohide EA et al (1995) The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 13:502–512PubMed Browman GP, Levine MN, Mohide EA et al (1995) The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol 13:502–512PubMed
7.
go back to reference Burch SE, Parker SA, Vann AM et al (1997) Measurement of 6-MV X-ray surface dose when topical agents are applied prior to external beam irradiation. Int J Radiat Oncol Biol Phys 38:447–451PubMed Burch SE, Parker SA, Vann AM et al (1997) Measurement of 6-MV X-ray surface dose when topical agents are applied prior to external beam irradiation. Int J Radiat Oncol Biol Phys 38:447–451PubMed
8.
go back to reference Campbell IR, Illingworth MH (1992) Can patients wash during radiotherapy to the breast or chest wall? A randomized controlled trial. Clin Oncol 4:78–82CrossRef Campbell IR, Illingworth MH (1992) Can patients wash during radiotherapy to the breast or chest wall? A randomized controlled trial. Clin Oncol 4:78–82CrossRef
9.
go back to reference Campbell J, Lane C (1996) Developing a skin-care protocol in radiotherapy. Prof Nurse 12:105–108PubMed Campbell J, Lane C (1996) Developing a skin-care protocol in radiotherapy. Prof Nurse 12:105–108PubMed
11.
go back to reference Dale PS, Tamhankar CP, George D et al (2001) Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects. Cancer Chemother Pharmacol 47:S29–S34 (Suppl)PubMedCrossRef Dale PS, Tamhankar CP, George D et al (2001) Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects. Cancer Chemother Pharmacol 47:S29–S34 (Suppl)PubMedCrossRef
12.
go back to reference Delaney G, Fisher R, Hook C et al (1997) Sulcrafate cream in the management of moist desquamation during radiotherapy. Australas Radiol 41:270–275PubMedCrossRef Delaney G, Fisher R, Hook C et al (1997) Sulcrafate cream in the management of moist desquamation during radiotherapy. Australas Radiol 41:270–275PubMedCrossRef
13.
go back to reference Dunst J, Semlin S, Pigorsch S et al (2000) Intermittent use of amifostine during postoperative radiochemotherapy and acute toxicity in rectal cancer patients. Strahlenther Onkol 176:416–421PubMedCrossRef Dunst J, Semlin S, Pigorsch S et al (2000) Intermittent use of amifostine during postoperative radiochemotherapy and acute toxicity in rectal cancer patients. Strahlenther Onkol 176:416–421PubMedCrossRef
14.
go back to reference Evensen JF, Bjordal K, Jacobsen A et al (2001) Effects of Na-sucrose octasulfate on skin and mucosa reactions during radiotherapy of head and neck cancers. Acta Oncol 40:751–755PubMedCrossRef Evensen JF, Bjordal K, Jacobsen A et al (2001) Effects of Na-sucrose octasulfate on skin and mucosa reactions during radiotherapy of head and neck cancers. Acta Oncol 40:751–755PubMedCrossRef
15.
go back to reference Fenig E, Brenner B, Katz A et al (2001) Topical biafine and lipiderm for the prevention of radiation dermatitis: a randomized prospective trial. Oncol Rep 8:305–309PubMed Fenig E, Brenner B, Katz A et al (2001) Topical biafine and lipiderm for the prevention of radiation dermatitis: a randomized prospective trial. Oncol Rep 8:305–309PubMed
16.
go back to reference Fisher J, Scott C, Stevens R et al (2000) Randomized phase III study comparing best supportive care to biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: radiation therapy oncology group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 48:1307–1310PubMed Fisher J, Scott C, Stevens R et al (2000) Randomized phase III study comparing best supportive care to biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: radiation therapy oncology group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 48:1307–1310PubMed
17.
go back to reference Frosch PJ, Kligman AM (1979) The soap chamber test: a new method for assessing the irritancy of soaps. J Am Acad Dermatol 1:35–41PubMedCrossRef Frosch PJ, Kligman AM (1979) The soap chamber test: a new method for assessing the irritancy of soaps. J Am Acad Dermatol 1:35–41PubMedCrossRef
18.
go back to reference Gujral MS, Patnaik PM, Kaul R et al (2001) Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers. Cancer Chemother Pharmacol 47:S23–S28 (Suppl)PubMedCrossRef Gujral MS, Patnaik PM, Kaul R et al (2001) Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers. Cancer Chemother Pharmacol 47:S23–S28 (Suppl)PubMedCrossRef
19.
go back to reference Halperin EC, Gaspar L, George S et al (1993) A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis. Int J Radiat Oncol Biol Phys 26:413–416PubMed Halperin EC, Gaspar L, George S et al (1993) A double-blind, randomized, prospective trial to evaluate topical vitamin C solution for the prevention of radiation dermatitis. Int J Radiat Oncol Biol Phys 26:413–416PubMed
20.
go back to reference Hazuka MB, Goebel RH, McCutchan S et al (1997) A new approach to the prevention of radiation-induced skin desquamation using a polymer adhesive skin sealant (PASS): final results of a prospective study (meeting abstract). Proc Am Soc Clin Oncol 16:A239 Hazuka MB, Goebel RH, McCutchan S et al (1997) A new approach to the prevention of radiation-induced skin desquamation using a polymer adhesive skin sealant (PASS): final results of a prospective study (meeting abstract). Proc Am Soc Clin Oncol 16:A239
21.
go back to reference Heggie S, Bryant GP, Tripcony L et al (2002) A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs 25:442–451PubMedCrossRef Heggie S, Bryant GP, Tripcony L et al (2002) A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs 25:442–451PubMedCrossRef
22.
go back to reference Kaul R, Mishra BK, Sutradar P et al (1999) The role of Wobe-Mugos in reducing acute sequele of radiation in head and neck cancers—a clinical phase III randomized trial. Indian J Cancer 36:141–148PubMed Kaul R, Mishra BK, Sutradar P et al (1999) The role of Wobe-Mugos in reducing acute sequele of radiation in head and neck cancers—a clinical phase III randomized trial. Indian J Cancer 36:141–148PubMed
23.
24.
go back to reference Koukourakis MI, Frangiadaki C, Stavroulaki A et al (2000) Subcutaneous amifostine during fractionated radiotherapy: a randomized phase II study in pelvic tumours J Clin Oncol 18:2226–2233PubMed Koukourakis MI, Frangiadaki C, Stavroulaki A et al (2000) Subcutaneous amifostine during fractionated radiotherapy: a randomized phase II study in pelvic tumours J Clin Oncol 18:2226–2233PubMed
25.
go back to reference Kouvaris JR, Kouloulias VE, Plataniotis GA et al (2001) Dermatits during radiation for vulvar carcinoma: prevention and treatment with granulocyte-macrophage colony-stimulating factor impregnated gauze. Wound Repair Regen 9:187–193PubMedCrossRef Kouvaris JR, Kouloulias VE, Plataniotis GA et al (2001) Dermatits during radiation for vulvar carcinoma: prevention and treatment with granulocyte-macrophage colony-stimulating factor impregnated gauze. Wound Repair Regen 9:187–193PubMedCrossRef
26.
go back to reference Lievens Y, Haustermans K, Van den Weyngaert D et al (1998) Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial. Radiother Oncol 47:149–153PubMedCrossRef Lievens Y, Haustermans K, Van den Weyngaert D et al (1998) Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial. Radiother Oncol 47:149–153PubMedCrossRef
27.
go back to reference Liguori V, Guillemin C, Pesce GF et al (1997) Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 42:155–161PubMedCrossRef Liguori V, Guillemin C, Pesce GF et al (1997) Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol 42:155–161PubMedCrossRef
28.
go back to reference Løkkevik E, Skovlund E, Reitan JB et al (1996) Skin treatment with bepanthen cream versus no cream during radiotherapy. Acta Oncol 35:1021–1026PubMedCrossRef Løkkevik E, Skovlund E, Reitan JB et al (1996) Skin treatment with bepanthen cream versus no cream during radiotherapy. Acta Oncol 35:1021–1026PubMedCrossRef
29.
go back to reference Maiche AG, Grohn P, Maki-Hokkonen H (1991) Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 30:395–396PubMedCrossRef Maiche AG, Grohn P, Maki-Hokkonen H (1991) Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 30:395–396PubMedCrossRef
30.
go back to reference Maiche A, Isokangas O, Grohn P (1994) Skin protection by sucralfate cream during electron beam therapy. Acta Oncol 33:201–203PubMedCrossRef Maiche A, Isokangas O, Grohn P (1994) Skin protection by sucralfate cream during electron beam therapy. Acta Oncol 33:201–203PubMedCrossRef
31.
go back to reference Mak SS, Lolassiotis A, Wan W et al (2000) The effects of hydrocolloid dressing and gentian violet on radiation-induced moist desquamation wound healing. Cancer Nurs 23:220–229PubMedCrossRef Mak SS, Lolassiotis A, Wan W et al (2000) The effects of hydrocolloid dressing and gentian violet on radiation-induced moist desquamation wound healing. Cancer Nurs 23:220–229PubMedCrossRef
32.
go back to reference Olsen DL, Raub W, Bradley C et al (2001) The effect of aloe vera gel/mild soap alone in preventing skin reaction in patients undergoing radiation therapy. Oncol Nurs Forum 28:543–547PubMed Olsen DL, Raub W, Bradley C et al (2001) The effect of aloe vera gel/mild soap alone in preventing skin reaction in patients undergoing radiation therapy. Oncol Nurs Forum 28:543–547PubMed
33.
go back to reference Oncology Nursing Society (ONS) (1998) Manual for radiation oncology nursing practice and education. Oncology Nursing Society, Pittsburgh, PA Oncology Nursing Society (ONS) (1998) Manual for radiation oncology nursing practice and education. Oncology Nursing Society, Pittsburgh, PA
34.
go back to reference Perez CA, Brady LW (1998) Principles and practice of radiation oncology, 3rd edn. Lippincott-Raven, Philadelphia, PA, p 11 Perez CA, Brady LW (1998) Principles and practice of radiation oncology, 3rd edn. Lippincott-Raven, Philadelphia, PA, p 11
35.
go back to reference Pommier P, Gomez F, Sunyach MP et al (2004) Phase III randomized trial of calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 22:1447–1453PubMedCrossRef Pommier P, Gomez F, Sunyach MP et al (2004) Phase III randomized trial of calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 22:1447–1453PubMedCrossRef
36.
go back to reference Potera ME, Lookingbill DP, Stryker JA (1982) Prophylaxis of radiation dermatitis with a topical cortisone cream. Radiother Oncol 143:775–777 Potera ME, Lookingbill DP, Stryker JA (1982) Prophylaxis of radiation dermatitis with a topical cortisone cream. Radiother Oncol 143:775–777
37.
go back to reference Roy I, Fortin A, Larochelle M (2001) The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol 58:333–339PubMedCrossRef Roy I, Fortin A, Larochelle M (2001) The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol 58:333–339PubMedCrossRef
38.
go back to reference Schmuth M, Wimmer MA, Hofer S et al (2002) Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol 146:983–991PubMedCrossRef Schmuth M, Wimmer MA, Hofer S et al (2002) Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol 146:983–991PubMedCrossRef
39.
go back to reference Schreck U, Paulsen F, Bamberg M et al (2002) Intraindividual comparison of two different skin care conceptions in patients undergoing radiotherapy of the head-and-neck region. Strahlenther Onkol 6:321–329CrossRef Schreck U, Paulsen F, Bamberg M et al (2002) Intraindividual comparison of two different skin care conceptions in patients undergoing radiotherapy of the head-and-neck region. Strahlenther Onkol 6:321–329CrossRef
40.
go back to reference Shell JA, Stanutz F, Grimm J (1986) Comparison of moisture vapor permeable (MVP) dressings to conventional dressings for management of radiation skin reactions. Oncol Nurs Forum 13:11–16PubMed Shell JA, Stanutz F, Grimm J (1986) Comparison of moisture vapor permeable (MVP) dressings to conventional dressings for management of radiation skin reactions. Oncol Nurs Forum 13:11–16PubMed
41.
go back to reference Simonen P, Hamilton C, Ferguson S et al (1998) Do inflammatory processes contribute to radiation induced erythema observed in the skin of humans? Radiother Oncol 46:73–82PubMedCrossRef Simonen P, Hamilton C, Ferguson S et al (1998) Do inflammatory processes contribute to radiation induced erythema observed in the skin of humans? Radiother Oncol 46:73–82PubMedCrossRef
42.
go back to reference Snyder CC (1986) Oncology nursing. Little, Brown and Company, Boston, MA Snyder CC (1986) Oncology nursing. Little, Brown and Company, Boston, MA
43.
go back to reference Snyder DS, Greenberg RA (1977) Radiographic measurement of topical corticosteriod-induced atrophy. J Invest Dermatol 279–281 Snyder DS, Greenberg RA (1977) Radiographic measurement of topical corticosteriod-induced atrophy. J Invest Dermatol 279–281
44.
go back to reference Szumacher E, Wighton A, Franssen E et al (2001) Phase II study assessing the effectiveness of biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy. Int J Radiat Oncol Biol Phys 51:81–86PubMed Szumacher E, Wighton A, Franssen E et al (2001) Phase II study assessing the effectiveness of biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy. Int J Radiat Oncol Biol Phys 51:81–86PubMed
45.
go back to reference Westbury C, Hines F, Hawkes E et al (2000) Advice on hair and scalp care during cranial radiotherapy: a prospective randomized trial. Radiother Oncol 54:109–116PubMedCrossRef Westbury C, Hines F, Hawkes E et al (2000) Advice on hair and scalp care during cranial radiotherapy: a prospective randomized trial. Radiother Oncol 54:109–116PubMedCrossRef
46.
go back to reference Williams MS, Burk M, Loprinzi CL et al (1996) Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 36:345–349PubMed Williams MS, Burk M, Loprinzi CL et al (1996) Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 36:345–349PubMed
Metadata
Title
The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline
Authors
Amanda Bolderston
Nancy S. Lloyd
Rebecca K. S. Wong
Lori Holden
Linda Robb-Blenderman
and the Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-based Care
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 8/2006
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0063-4

Other articles of this Issue 8/2006

Supportive Care in Cancer 8/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine